- Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer
-
Lee JH, Kim SH, Oh SY, Lee S, Lee H, Lee HJ, Kim HJ
- KMID: 1776453
- Korean J Intern Med.
- 2013 May;28(3):314-321.
- doi: 10.3904/kjim.2013.28.3.314
BACKGROUND/AIMS: To determine the efficacy and toxicity of docetaxel as a third-line therapy for patients with relapsed gastric cancer who have undergone modified oxaliplatin-fluorouracil (m-FOLFOX)-4 and modified irinotecan-fluorouracil (m-FOLFIRI) regimens. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
